Based in Manchester, UK, Euprotec specialises in the provision of high quality and cost effective infectious disease biology services to organisations involved in antibacterial drug discovery and development.

Our team has developed a high level of expertise in microbiology, infectious disease biology, ADME/PK and has been involved in the discovery and development of several novel drugs which have either reached the market or are currently in clinical development. Our experience encompasses many aspects of drug discovery and development including:

• Compound collection screening/hit-finding
• Development, validation and execution of both new and more established assays and models to support Hit-to-Lead and Lead Optimisation
• Generation of Proof-of-Concept data
• ADMET and PK

Euprotec has worked across a wide range of biological targets and with multiple classes of antimicrobial agent including small molecules, natural products, peptides and biologics.

The Company has collected and continues to develop an extensive library of clinical isolates known as StrainBank. This collection is a unique resource and represents a valuable tool to organisations involved in antibacterial drug discovery and development.

Euprotec has established itself in industry leading laboratories and continues to develop a broad client base. We have successfully delivered results to our clients and have significantly contributed to their ongoing drug discovery programs. In order to meet the changing needs of our partners, Euprotec continues to invest in the development of new assays and models to help predict therapeutic outcome.